Erkan Topkan

1.9k total citations
129 papers, 1.2k citations indexed

About

Erkan Topkan is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Otorhinolaryngology. According to data from OpenAlex, Erkan Topkan has authored 129 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Pulmonary and Respiratory Medicine, 61 papers in Oncology and 37 papers in Otorhinolaryngology. Recurrent topics in Erkan Topkan's work include Head and Neck Cancer Studies (37 papers), Inflammatory Biomarkers in Disease Prognosis (33 papers) and Lung Cancer Diagnosis and Treatment (28 papers). Erkan Topkan is often cited by papers focused on Head and Neck Cancer Studies (37 papers), Inflammatory Biomarkers in Disease Prognosis (33 papers) and Lung Cancer Diagnosis and Treatment (28 papers). Erkan Topkan collaborates with scholars based in Türkiye, United States and Cyprus. Erkan Topkan's co-authors include Uğur Selek, Berrin Pehlivan, Cem Önal, Cem Parlak, Melek Yavuz, Yurday Özdemir, Hüseyin Mertsoylu, Ahmet Küçük, Ali Ayberk Beşen and Berna Akkuş Yıldırım and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Erkan Topkan

117 papers receiving 1.2k citations

Peers

Erkan Topkan
Susannah Yovino United States
Daniel Shasha United States
C.F. Hess Germany
Najeeb Mohideen United States
Jae Myoung Noh South Korea
Susannah Yovino United States
Erkan Topkan
Citations per year, relative to Erkan Topkan Erkan Topkan (= 1×) peers Susannah Yovino

Countries citing papers authored by Erkan Topkan

Since Specialization
Citations

This map shows the geographic impact of Erkan Topkan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erkan Topkan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erkan Topkan more than expected).

Fields of papers citing papers by Erkan Topkan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erkan Topkan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erkan Topkan. The network helps show where Erkan Topkan may publish in the future.

Co-authorship network of co-authors of Erkan Topkan

This figure shows the co-authorship network connecting the top 25 collaborators of Erkan Topkan. A scholar is included among the top collaborators of Erkan Topkan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erkan Topkan. Erkan Topkan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Topkan, Erkan, et al.. (2024). Prognostic Value of Novel CARWL Score in Stage IIIC Non‐Small‐Cell Lung Cancer Patients Undergoing Concurrent Chemoradiotherapy. Canadian Respiratory Journal. 2024(1). 2803044–2803044. 2 indexed citations
3.
Somay, Efsun, Büşra Yılmaz, Erkan Topkan, Berrin Pehlivan, & Uğur Selek. (2023). Low hemoglobin levels predict increased radiation‐induced trismus rates in nasopharyngeal cancer. Oral Diseases. 30(3). 1052–1060. 3 indexed citations
4.
Topkan, Erkan, Efsun Somay, Büşra Yılmaz, Berrin Pehlivan, & Uğur Selek. (2023). Valero’s host index is useful in predicting radiation-induced trismus and osteoradionecrosis of the jaw risks in locally advanced nasopharyngeal carcinoma patients. BMC Cancer. 23(1). 5 indexed citations
5.
Topkan, Erkan, Ahmet Küçük, Efsun Somay, et al.. (2023). Review of Osteoradionecrosis of the Jaw: Radiotherapy Modality, Technique, and Dose as Risk Factors. Journal of Clinical Medicine. 12(8). 3025–3025. 13 indexed citations
7.
Somay, Efsun, Büşra Yılmaz, Erkan Topkan, et al.. (2022). Initial neutrophil‐to‐lymphocyte ratio predicts radiation‐induced trismus in parotid gland cancer. Oral Diseases. 29(7). 2772–2779. 8 indexed citations
8.
Somay, Efsun, Büşra Yılmaz, Erkan Topkan, et al.. (2022). Hemoglobin‐to‐platelet ratio in predicting the incidence of trismus after concurrent chemoradiotherapy. Oral Diseases. 29(7). 2962–2970. 8 indexed citations
9.
Topkan, Erkan, et al.. (2022). High Measures of Pre-Chemoradiotherapy Platelet-to-Albumin Ratio Indicates Poor Prognosis in Locally Advanced Pancreatic Cancer Patients. SHILAP Revista de lepidopterología. 5 indexed citations
10.
Topkan, Erkan, Ahmet Küçük, & Uğur Selek. (2022). Pretreatment Pan-Immune-Inflammation Value Efficiently Predicts Survival Outcomes in Glioblastoma Multiforme Patients Receiving Radiotherapy and Temozolomide. Journal of Immunology Research. 2022. 1–9. 11 indexed citations
11.
Topkan, Erkan, Uğur Selek, Ahmet Küçük, & Berrin Pehlivan. (2022). Low Pre-ChemoradiotherapyPan-Immune-Inflammation Value (PIV) Measures Predict Better Survival Outcomes in Locally Advanced Pancreatic Adenocarcinomas. Journal of Inflammation Research. Volume 15. 5413–5423. 23 indexed citations
12.
Topkan, Erkan, Uğur Selek, Ahmet Küçük, et al.. (2022). Postchemoradiotherapy Neutrophil‐to‐Lymphocyte Ratio Predicts Distant Metastasis and Survival Results in Locally Advanced Pancreatic Cancers. International Journal of Clinical Practice. 2022(1). 7473649–7473649. 1 indexed citations
14.
Özdemir, Yurday, Erkan Topkan, Hüseyin Mertsoylu, & Uğur Selek. (2020). Low Prognostic Nutritional Index Predicts Poor Clinical Outcomes in Patients with Stage IIIB Non-small-cell Lung Carcinoma Undergoing Chemoradiotherapy. SHILAP Revista de lepidopterología. 4 indexed citations
15.
Topkan, Erkan, Hüseyin Mertsoylu, Ahmet Küçük, et al.. (2020). Low Systemic Inflammation Response Index Predicts Good Prognosis in Locally Advanced Pancreatic Carcinoma Patients Treated with Concurrent Chemoradiotherapy. Gastroenterology Research and Practice. 2020. 1–8. 28 indexed citations
17.
Topkan, Erkan, Yurday Özdemir, Ahmet Küçük, et al.. (2020). Low Advanced Lung Cancer Inflammation Index Predicts Poor Prognosis in Locally Advanced Nasopharyngeal Carcinoma Patients Treated with Definitive Concurrent Chemoradiotherapy. Journal of Oncology. 2020. 1–10. 7 indexed citations
18.
Topkan, Erkan, Ahmet Küçük, Yurday Özdemir, et al.. (2020). Systemic Inflammation Response Index Predicts Survival Outcomes in Glioblastoma Multiforme Patients Treated with Standard Stupp Protocol. Journal of Immunology Research. 2020(1). 8628540–8628540. 35 indexed citations
19.
Topkan, Erkan, Ali Ayberk Beşen, Hüseyin Mertsoylu, et al.. (2020). Prognostic Value of C-Reactive Protein to Albumin Ratio in Glioblastoma Multiforme Patients Treated with Concurrent Radiotherapy and Temozolomide. International Journal of Inflammation. 2020. 1–8. 9 indexed citations
20.
Mertsoylu, Hüseyin, et al.. (2019). Chemoradiotherapy-induced Cochlear Toxicity. International Journal of Scientific Research and Management (IJSRM). 7(9).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026